Literature DB >> 9397940

Expression of insulin-like growth factor-I (IGF-I) receptor gene in rat brain and liver during development and in regenerating adult rat liver.

A Santos1, B Yusta, M D Fernández-Moreno, E Blázquez.   

Abstract

Insulin-like growth factor-I (IGF-I) is involved in the growth and development of liver and brain during fetal life by acting through specific plasma membrane receptors. In an attempt to determine how the changes in IGF-I receptor number are regulated during development, we have compared [125I]IGF-I binding to membrane fractions with the concentration of IGF-I receptor mRNA in rat liver and brain. IGF-I binding to liver membranes was 4.5 times higher in 20-day-old fetuses than in adult rats. After partial hepatectomy (70%) in adult rats a transient 2-fold increase of IGF-I binding to liver membranes was observed. In fetal and regenerating liver increases similar to those observed for IGF-I binding were observed in IGF-I receptor mRNA concentrations. In brain microsomes IGF-I binding was 3.5 times higher in 20-day-old fetuses than in adults. This difference reflects a similar change in the number of IGF-I receptors without modifications in the affinity of the receptor for the ligand. In contrast to the liver, no significant changes in the concentration of IGF-I receptor mRNA were observed in the developing brain when determined by hybridization solution, Northern blot or RNase protection analysis. These findings suggest that in the liver, the IGF-I receptor gene is regulated at pretranslational level during development and regeneration, while in brain it is preferentially regulated at translational or posttranslational level.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9397940     DOI: 10.1016/0303-7207(94)90222-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation.

Authors:  P M Yamada; H H Mehta; D Hwang; K P Roos; A L Hevener; K W Lee
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

2.  Expressed genes in regenerating rat liver after partial hepatectomy.

Authors:  Cun-Shuan Xu; Cui-Fang Chang; Jin-Yun Yuan; Wen-Qiang Li; Hong-Peng Han; Ke-Jin Yang; Li-Feng Zhao; Yu-Chang Li; Hui-Yong Zhang; Salman Rahman; Jing-Bo Zhang
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

Review 3.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

Review 4.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

5.  Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C.

Authors:  Jose Tadeu Stefano; Maria Lucia Correa-Giannella; Cristiane Maria Freitas Ribeiro; Venancio Avancini Ferreira Alves; Paulo Celso Bosco Massarollo; Marcel Cerqueira Cesar Machado; Daniel Giannella-Neto
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

6.  Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met.

Authors:  Nadia Harun; Patricia Costa; C Christophi
Journal:  Clin Exp Metastasis       Date:  2013-07-31       Impact factor: 5.150

Review 7.  The role of the insulin-like growth factors in the central nervous system.

Authors:  A J D'Ercole; P Ye; A S Calikoglu; G Gutierrez-Ospina
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

8.  GH modulates hepatic epidermal growth factor signaling in the mouse.

Authors:  Lorena González; Ma Eugenia Díaz; Johanna G Miquet; Ana I Sotelo; Diego Fernández; Fernando P Dominici; Andrzej Bartke; Daniel Turyn
Journal:  J Endocrinol       Date:  2009-12-23       Impact factor: 4.286

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.